180 related articles for article (PubMed ID: 24852801)
1. Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials.
Iqbal J; Vergouwe Y; Bourantas CV; van Klaveren D; Zhang YJ; Campos CM; García-García HM; Morel MA; Valgimigli M; Windecker S; Steyerberg EW; Serruys PW
JACC Cardiovasc Interv; 2014 May; 7(5):464-70. PubMed ID: 24852801
[TBL] [Abstract][Full Text] [Related]
2. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery.
Capodanno D; Giacoppo D; Dipasqua F; Miccichè E; Licitra C; Di Salvo ME; Francaviglia B; Grasso C; La Manna A; Sgroi C; Tamburino C
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E446-52. PubMed ID: 23592634
[TBL] [Abstract][Full Text] [Related]
4. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
Hara H; Kogame N; Takahashi K; Modolo R; Chichareon P; Tomaniak M; Ono M; Kawashima H; Gao C; Wang R; Valkov VD; Vom Dahl J; Steinwender C; Geisler T; Lemos Neto PA; Macaya Miguel C; Garg S; Jüni P; Hamm C; Steg PG; Valgimigli M; Vranckx P; Windecker S; Farooq V; Onuma Y; Serruys PW;
Catheter Cardiovasc Interv; 2020 Nov; 96(5):E516-E526. PubMed ID: 32294317
[TBL] [Abstract][Full Text] [Related]
6. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
Farooq V; van Klaveren D; Steyerberg EW; Meliga E; Vergouwe Y; Chieffo A; Kappetein AP; Colombo A; Holmes DR; Mack M; Feldman T; Morice MC; Ståhle E; Onuma Y; Morel MA; Garcia-Garcia HM; van Es GA; Dawkins KD; Mohr FW; Serruys PW
Lancet; 2013 Feb; 381(9867):639-50. PubMed ID: 23439103
[TBL] [Abstract][Full Text] [Related]
7. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
8. Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
Gao G; Zhang D; Song C; Xu H; Yin D; Guan C; Yang Y; Xu B; Dou K
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():534-541. PubMed ID: 31876352
[TBL] [Abstract][Full Text] [Related]
9. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
[TBL] [Abstract][Full Text] [Related]
10. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
[TBL] [Abstract][Full Text] [Related]
11. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
12. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
Takahashi K; Serruys PW; Fuster V; Farkouh ME; Spertus JA; Cohen DJ; Park SJ; Park DW; Ahn JM; Kappetein AP; Head SJ; Thuijs DJ; Onuma Y; Kent DM; Steyerberg EW; van Klaveren D;
Lancet; 2020 Oct; 396(10260):1399-1412. PubMed ID: 33038944
[TBL] [Abstract][Full Text] [Related]
13. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
Migliorini A; Valenti R; Parodi G; Vergara R; Buonamici P; Cerisano G; Carrabba N; Antoniucci D
JACC Cardiovasc Interv; 2016 May; 9(10):1001-7. PubMed ID: 27198680
[TBL] [Abstract][Full Text] [Related]
14. Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation.
Malkin CJ; George V; Ghobrial MS; Krishnan A; Siotia A; Raina T; Morton AC; Gunn J
EuroIntervention; 2013 Mar; 8(11):1286-95. PubMed ID: 23538157
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
Song Y; Gao Z; Tang X; Ma Y; Jiang P; Xu J; Yao Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
Catheter Cardiovasc Interv; 2018 Jul; 92(1):40-47. PubMed ID: 28895284
[TBL] [Abstract][Full Text] [Related]
16. Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study).
Cerrato E; Barbero U; Quadri G; Ryan N; D'Ascenzo F; Tomassini F; Quirós A; Bellucca S; Conrotto F; Ugo F; Kawamoto H; Rolfo C; Pavani M; Mejia-Renteria H; Gili S; Iannaccone M; Debenedictis M; Baldassarre D; Biondi-Zoccai G; Colombo A; Varbella F; Escaned J
Catheter Cardiovasc Interv; 2020 Jul; 96(1):E17-E26. PubMed ID: 31478334
[TBL] [Abstract][Full Text] [Related]
17. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
[TBL] [Abstract][Full Text] [Related]
18. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.
Farooq V; Vergouwe Y; Räber L; Vranckx P; Garcia-Garcia H; Diletti R; Kappetein AP; Morel MA; de Vries T; Swart M; Valgimigli M; Dawkins KD; Windecker S; Steyerberg EW; Serruys PW
Eur Heart J; 2012 Dec; 33(24):3098-104. PubMed ID: 23048195
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the prognostic value of SYNTAX score and clinical SYNTAX score on outcomes of Chinese patients underwent percutaneous coronary intervention.
Li XQ; Yin C; Li XL; Wu WL; Cui K
BMC Cardiovasc Disord; 2021 Jul; 21(1):334. PubMed ID: 34233618
[TBL] [Abstract][Full Text] [Related]
20. Beyond the SYNTAX score--advantages and limitations of other risk assessment systems in left main percutaneous coronary intervention.
Capodanno D
Circ J; 2013; 77(5):1131-8. PubMed ID: 23546417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
